JPH07252158A - Antiallergic agent from rice - Google Patents
Antiallergic agent from riceInfo
- Publication number
- JPH07252158A JPH07252158A JP6302636A JP30263694A JPH07252158A JP H07252158 A JPH07252158 A JP H07252158A JP 6302636 A JP6302636 A JP 6302636A JP 30263694 A JP30263694 A JP 30263694A JP H07252158 A JPH07252158 A JP H07252158A
- Authority
- JP
- Japan
- Prior art keywords
- rice
- product
- present
- germinated
- koji
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 86
- 235000009566 rice Nutrition 0.000 title claims abstract description 85
- 239000000043 antiallergic agent Substances 0.000 title claims abstract description 16
- 240000007594 Oryza sativa Species 0.000 title description 67
- 238000000605 extraction Methods 0.000 claims abstract description 17
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 11
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 9
- 241000209094 Oryza Species 0.000 claims abstract 19
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 19
- 238000000855 fermentation Methods 0.000 abstract description 16
- 230000004151 fermentation Effects 0.000 abstract description 16
- 239000002994 raw material Substances 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 5
- 150000007524 organic acids Chemical class 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 239000000047 product Substances 0.000 description 90
- 235000021329 brown rice Nutrition 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 19
- 108090000790 Enzymes Proteins 0.000 description 19
- 229940088598 enzyme Drugs 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- 230000000593 degrading effect Effects 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 230000000172 allergic effect Effects 0.000 description 6
- 230000003266 anti-allergic effect Effects 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- -1 allergic vasculitis Chemical class 0.000 description 4
- 230000035784 germination Effects 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000002366 lipolytic effect Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- YQEMORVAKMFKLG-UHFFFAOYSA-N 2-stearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010061430 Arthritis allergic Diseases 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000032514 Leukocytoclastic vasculitis Diseases 0.000 description 1
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- 240000002582 Oryza sativa Indica Group Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000002029 allergic contact dermatitis Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
(57)【要約】
【目的】 安全で安価であって、原料供給が安定してお
り、加工が容易で、長期に亘って常用しても全く安全な
抗アレルギー剤を提供する。
【構成】 発芽させた米の粉砕物、米または発芽さ
せた米の抽出物、米または発芽させた米の加水物を酵
素分解または麹を作用させたもの、米または発芽させ
た米を抽出するに当たり、その抽出前、抽出と同時また
は抽出後に酵素分解または麹を作用させたもの、米ま
たは発芽させた米の抽出物あるいは酵素分解または麹を
作用させたものに、アルコール発酵あるいは有機酸発酵
を行なったもの、以上それぞれをそのまま、あるいはこ
れを含有してなる米からの抗アレルギー剤。(57) [Summary] [Objective] To provide an antiallergic agent which is safe and inexpensive, has stable supply of raw materials, is easy to process, and is completely safe even if it is used regularly for a long period of time. [Structure] Smashed germinated rice, rice or germinated rice extract, rice or germinated rice hydrolyzed with enzymatic decomposition or koji, rice or germinated rice are extracted Prior to the extraction, at the same time as or after the extraction, those subjected to enzymatic decomposition or koji, the extract of rice or sprouted rice or those subjected to enzymatic decomposition or koji, were subjected to alcohol fermentation or organic acid fermentation. Antiallergic agent from rice that has been performed, or each of them as they are, or containing them.
Description
【0001】[0001]
【産業上の利用分野】本発明は、米または発芽させた米
を原料として得られる抗アレルギー剤に関するものであ
る。TECHNICAL FIELD The present invention relates to an antiallergic agent obtained from rice or sprouted rice as a raw material.
【0002】[0002]
【従来の技術】現在、米は主食以外に、清酒,焼酎,み
りん,酢,麹などとして用途開発され、古くから生活に
欠かせないものとなっている。このほかには、美容的用
途として糠袋が知られている。これらは米を単なる主食
であると見るか、またはせいぜい澱粉源としてしか見て
いなかったということによるものであると思われる。ま
た、糠袋にしても、皮膚によいとされ、慣例的にそのま
ま使用されてきたのみであり、有効成分という概念もな
ければ、その有効成分を利用するという考え方も全くな
かったのである。2. Description of the Related Art At present, rice has been developed as a staple food, as well as sake, shochu, mirin, vinegar, koji, etc., and has been indispensable for life since ancient times. In addition to this, bran bags are known for cosmetic purposes. It is believed that these were due to the fact that rice was viewed as merely a staple food, or at best as a source of starch. Also, even if the bran bag is said to be good for the skin, it has been customarily used as it is, and there was no concept of an active ingredient, nor was there any idea of utilizing that active ingredient.
【0003】一方、免疫応答に質的、量的な変化が生じ
て、調節機能の異常、特に過剰な免疫応答が起こり、体
に障害をきたすアレルギーに苦しむ人が多くなってきて
いる。このアレルギーに対して様々な治療が試みられて
いるが、薬剤では投与による副作用や使用量、使用期間
に制限の問題があり、長期に亘る服用により起こる安全
性の面からも問題になっており、ただアレルギーの原因
となる抗原に接さないようにするしか顕著な治療はな
い。すなわち、アレルギーに対して有効で、しかも、副
作用がなく安全な抗アレルギー剤は、未だ開発されてい
ないのが現状である。On the other hand, an increasing number of people are suffering from allergies that damage the body due to qualitative and quantitative changes in the immune response, resulting in abnormal regulatory function, especially excessive immune response. Various treatments have been attempted for this allergy, but the drug has side effects due to administration, restrictions on the amount used, and the period of use, which is also a problem from the viewpoint of safety caused by long-term administration. , There is a remarkable treatment only to avoid contact with the antigen that causes allergies. In other words, the present situation is that an antiallergic agent that is effective against allergies and has no side effects and is safe has not yet been developed.
【0004】[0004]
【発明が解決しようとする課題】現在、薬剤の人体に対
する副作用が問題となっており、全く副作用がなく、し
かも、長期に亘って常用しても十分に安全な抗アレルギ
ー剤が要求されている。本発明は、安全で安価であっ
て、原料供給が安定しており、加工が容易で、長期に亘
って常用しても全く安全な米からの、抗アレルギー剤を
提供することを目的とするものである。At present, side effects of drugs on the human body have become a problem, and there is a demand for antiallergic agents that have no side effects and are sufficiently safe even if they are used regularly for a long period of time. . It is an object of the present invention to provide an antiallergic agent from rice that is safe and inexpensive, has a stable supply of raw materials, is easy to process, and is completely safe even after long-term regular use. It is a thing.
【0005】[0005]
【課題を解決するための手段】本発明者らは、動植物合
和すの観点から、主食である米を中心に種々の植物成分
の研究を進めてきた。その過程で、米には今まで予測で
きなかった数多くの可能性および効果があることが判明
してきた。そこで、主食として用いられ、安全性が最も
高いことが実証されている米をテーマとして取り上げ、
米の総合利用研究を行ってきた。そのうちの一つのテー
マとして、米からの抗アレルギー剤について鋭意研究を
重ねてきたのであるが、その過程で、米および発芽させ
た米には抗アレルギー剤としての効果を有する成分が含
有させていることを見出し、本発明を完成するに至っ
た。[Means for Solving the Problems] From the viewpoint of animal and plant harmony, the present inventors have conducted research on various plant components centering on rice, which is a staple food. In the process, it has become clear that rice has a number of potential and benefits that were previously unpredictable. Therefore, we picked up rice, which is used as a staple food and proved to have the highest safety, as the theme,
I have conducted comprehensive utilization research on rice. As one of the themes, we have conducted intensive research on antiallergic agents from rice, and in the process, rice and germinated rice contain ingredients that have antiallergic effects. This has led to the completion of the present invention.
【0006】本発明において、米および発芽させた米に
含有されている抗アレルギー効果を有する成分は、未だ
解明するに至っていないが、米および発芽させた米を、
下記のように処理したものは、抗アレルギー効果を示す
ことが判明した。 発芽させた米の粉砕物をそのまま、あるいはこれを
含有してなるもの。 米または発芽させた米の抽出物をそのまま、あるい
はこれを含有してなるもの。In the present invention, the components having an antiallergic effect contained in rice and germinated rice have not yet been elucidated, but rice and germinated rice are
Those treated as described below were found to exhibit anti-allergic effects. Sprouted crushed rice as it is or containing it. Rice or germinated rice extract as it is or containing it.
【0007】 米および発芽させた米の加水物を酵素
分解または麹を作用させたものをそのまま、あるいはこ
れを含有してなるもの。 米または発芽させた米を抽出するに当たり、その抽
出前、抽出と同時または抽出後に酵素分解または麹を作
用させたものをそのまま、あるいはこれを含有してなる
もの。 米または発芽させた米の抽出物あるいは酵素分解ま
たは麹を作用させたものに、アルコール発酵あるいは有
機酸発酵を行なったものをそのまま、あるいはこれを含
有してなるもの。 ここでいうアレルギーとは、アレルギー性胃炎、アレル
ギー性結膜炎、アレルギー性接触皮膚炎、アレルギー性
体質、アレルギー性鼻炎等アレルギーにより起こる疾患
全てを指す。[0007] A product obtained by enzymatically decomposing or hydrolyzing rice and germinated rice water as it is, or containing it. When extracting rice or sprouted rice, the one that has been subjected to enzymatic decomposition or koji before or at the same time as or after the extraction is used as it is or containing it. An extract of rice or germinated rice or a product of enzymatic decomposition or koji which has been subjected to alcohol fermentation or organic acid fermentation as it is or containing it. The term "allergy" as used herein refers to all diseases caused by allergy such as allergic gastritis, allergic conjunctivitis, allergic contact dermatitis, allergic constitution and allergic rhinitis.
【0008】本発明で使用される米とは、ジャポニカ,
インディカ米を問わず、うるち米、および餅米等の玄米
および白米を指し、品種,種類は問わない。さらに、精
白時に出てくる92%以上の赤糠、あるいは92%以下
の白糠を使用してもよく、安価で経済的である。また、
発芽させた米が使用される。なお、有効成分は、熱およ
び光に対して安定であるため、上記の原料は、浸漬,蒸
煮,焙煎(砂焙り,網焙り,熱風焙煎等全てを指す),
蒸煮焙煎,凍結乾燥等の表面変性,UV照射等の光変
性,パットライス等の加圧焙煎,揚げる等の原料処理を
してもよく、また、効果も変わらなかった。The rice used in the present invention means japonica,
Regardless of indica rice, it refers to non-glutinous rice and brown rice such as sticky rice and white rice, regardless of variety and type. Further, 92% or more of red rice bran or 92% or less of white rice bran, which appears during whitening, may be used, which is inexpensive and economical. Also,
Germinated rice is used. Since the active ingredient is stable against heat and light, the above raw materials are dipping, steaming, roasting (all sand roasting, net roasting, hot air roasting, etc.),
Raw material treatment such as steam roasting, surface modification such as freeze-drying, photo-modification such as UV irradiation, pressure roasting such as Patrice, and frying may be performed, and the effect was not changed.
【0009】米および発芽させた米は、そのまま用いて
も有効であるが、実用上の面から粉砕して用いるのが好
ましい。米および発芽させた米を粉砕して粉体化するに
は、粉砕機または精米機を用い一般的な方法で行なえば
よい。米を発芽させる場合、胚芽のついた米を水に浸漬
あるいは水を噴霧して発芽させる。発芽させる時の温度
は5〜70℃である。ただし、発芽さえすれば、温度お
よび時間は問わない。また、発芽中に水が腐敗する危険
性がある場合は、腐敗しないように水を取り替えるか、
何らかの防腐を行うのが好ましい。ここで、発芽とは、
発芽する直前から発芽したものまで全てを指す。この発
芽させた米をよく洗浄して用いる。この時、乾燥して用
いてもよい。Although the rice and germinated rice are effective as they are, they are preferably crushed for practical use. In order to pulverize the rice and the sprouted rice into powder, a pulverizer or a rice mill may be used by a general method. When sprouting rice, germinated rice is soaked in water or sprayed with water to germinate. The temperature for germination is 5 to 70 ° C. However, the temperature and time do not matter as long as they germinate. Also, if there is a risk of water spoiling during germination, replace the water so that it does not decay, or
It is preferable to carry out some preservatives. Here, germination means
It refers to everything from just before germination to germinated ones. The germinated rice is washed well before use. At this time, it may be dried before use.
【0010】米または発芽させた米を抽出、あるいは酵
素分解または麹を作用させる場合、原料の米を粉砕して
顆粒あるいは粉体化すると、表面積が大きくなるため効
率がよくなる。粉砕しなくてもよいが、この場合には、
米組織の分解および抽出に長時間を要する。When extracting rice or germinated rice, or subjecting it to enzymatic decomposition or koji, the raw material rice is pulverized into granules or powders, thereby increasing the surface area and improving efficiency. You don't have to grind, but in this case,
It takes a long time to decompose and extract the rice tissue.
【0011】米または発芽させた米を水抽出する場合、
抽出温度は、高温が効率的であるが、低温でも十分に抽
出を行うことができる。ただし、40℃以下の低温の場
合は、pHを酸性あるいはアルカリ性にするか、防腐剤
あるいはアルコールを加えて、米が腐敗しないように処
理することが望ましい。抽出時間は、有効成分さえ抽出
できれば、長くても短くてもよく、抽出温度,抽出時間
により定めればよい。また、抽出は、加圧下または常圧
下で行っても、減圧下で行ってもよい。When extracting rice or sprouted rice with water,
High extraction temperature is efficient, but extraction can be sufficiently performed even at low temperature. However, at a low temperature of 40 ° C. or lower, it is desirable to make the pH acidic or alkaline, or add a preservative or alcohol to treat the rice so that it does not spoil. The extraction time may be long or short as long as the effective component can be extracted, and may be determined by the extraction temperature and the extraction time. The extraction may be carried out under pressure, at normal pressure, or under reduced pressure.
【0012】水抽出の場合、最も問題になるのは糊化現
象である。糊状になれば、抽出効率が悪くなるばかりで
なく、実作業においては困難を極める。これを防ぐため
には、アミラーゼを加えて反応させるか、塩酸などで酸
性にして澱粉を切ってやればよく、この方法を用いるこ
とにより、十分に解決でき、実用上も全く問題はない。[0012] In the case of water extraction, the gelatinization phenomenon is the most problematic. If it becomes pasty, not only the extraction efficiency will deteriorate, but it will be extremely difficult in actual work. In order to prevent this, the reaction may be carried out by adding amylase or acidification may be carried out with hydrochloric acid or the like to cut the starch. By using this method, it can be sufficiently solved and there is no problem in practice.
【0013】抽出物中の有効成分は、酸,アルカリに安
定であるためか、酸分解抽出、あるいはアルカリ分解抽
出を行うのも有効である。この場合、必要により中和、
脱塩を行う。有機溶媒で抽出する場合も、米はなるべく
微粉砕または粉体化して抽出することが望ましい。有機
溶媒はアルコール,アセトン,n−ヘキサン,メタノー
ル等の一般的な有機溶媒でよいが、人体に対して有害な
ものは抽出後、溶媒を完全に除去する必要があるので安
全なものがよい。Since the active ingredient in the extract is stable to acid and alkali, it is also effective to carry out acid decomposition extraction or alkali decomposition extraction. In this case, neutralize if necessary,
Desalt. Also when extracting with an organic solvent, it is desirable to pulverize or pulverize rice as much as possible before extracting. The organic solvent may be a general organic solvent such as alcohol, acetone, n-hexane, methanol, etc., but if it is harmful to the human body, it is necessary to completely remove the solvent after extraction, so a safe one is preferable.
【0014】また、米あるいは発芽させた米を酵素分
解、または麹を作用させてもよい。ここで言う酵素分解
とは、澱粉分解酵素,蛋白分解酵素,脂肪分解酵素,繊
維分解酵素,リグニン分解酵素,ペクチン分解酵素等米
に働く酵素全てを指し、これらを1種または2種以上作
用させることをいう。また、麹とは麹菌の種類および米
の品種,種類は問わない。さらに、前記の抽出を行うに
当り、抽出の前、抽出と同時または抽出の後に、上記の
酵素分解および麹を作用させてもよい。Further, rice or germinated rice may be enzymatically decomposed or koji may be allowed to act thereon. The term "enzymatic degradation" as used herein refers to all enzymes that act on rice, such as starch degrading enzymes, proteolytic enzymes, lipolytic enzymes, fiber degrading enzymes, lignin degrading enzymes, pectin degrading enzymes, and one or more of these are allowed to act. Say that. The koji may be any type of koji mold or rice variety and type. Furthermore, in carrying out the above-mentioned extraction, the above-mentioned enzymatic decomposition and koji may be allowed to act before, simultaneously with or after the extraction.
【0015】本発明においては、さらに上記の処理を行
なうと同時または処理後、アルコール発酵あるいは乳酸
発酵、酢酸発酵等の有機酸発酵を行うと、次のような点
で有効である。まず、アルコール発酵を行なえば、塗布
時にベタツキがないばかりか、濃縮がしやすく、有効成
分の濃縮が容易になる。また、乳酸発酵は飲料等の用途
に使用する場合、風味をよくし、酢酸発酵は酢という調
味液用途として本発明品を利用することができ、有機酸
発酵することにより幅広い用途として使用することがで
きる。In the present invention, it is effective to carry out the organic acid fermentation such as alcohol fermentation, lactic acid fermentation or acetic acid fermentation at the same time as or after the above-mentioned treatment, in the following points. First, if alcohol fermentation is carried out, not only there is no stickiness at the time of application, but also the concentration is easy and the active ingredient can be easily concentrated. Further, when lactic acid fermentation is used for applications such as beverages, the product of the present invention can be used as a seasoning liquid application of vinegar for improving flavor, and acetic acid fermentation can be used as a wide range of applications by organic acid fermentation. You can
【0016】また、92%以上の赤糠部分を調べてみた
ところ、効果はあるが、弱いことが判明した。以上のよ
うにして得られた本発明品は、残渣を分離することなく
そのまま、あるいは圧搾、濾過して用いる。そのまま用
いるときは、殺菌あるいは除菌をしてて製品にする。な
お、必要により酵母による通気発酵、アルコール沈殿、
合成吸着剤等で除糖を行なってもよい。また、本発明品
を配合する場合は、実際の用途に応じ、常法にしたがっ
てクリーム、洗顔料、乳液、化粧水、クレンジング、パ
ック、石鹸などの化粧料、軟膏剤、パスタ剤、ローショ
ン剤、チンキ剤、リエメント剤、ゼリー剤、エアゾール
剤などの外用薬品のような剤型にする。他の配合成分
は、通常用いられるものいずれでもよく、さらに、他の
薬効剤を併用してもよい。Further, when the red bran portion of 92% or more was examined, it was found to be effective but weak. The product of the present invention obtained as described above is used as it is without separating the residue, or after being pressed and filtered. When it is used as it is, it is sterilized or sterilized to obtain a product. If necessary, aeration fermentation with yeast, alcohol precipitation,
You may remove sugar with a synthetic adsorbent. Further, when the product of the present invention is blended, depending on the actual application, creams, facial cleansers, milky lotions, lotions, cleansing, packs, cosmetics such as soaps, ointments, pasta agents, lotions, etc. Formulations such as tinctures, relief agents, jellies, aerosols and other external medicines. The other compounding ingredients may be any of those usually used, and further, other medicinal agents may be used in combination.
【0017】本発明品の抗アレルギー作用について調べ
た結果を以下に記載する。 (1) ヒスタミン遊離抑制作用 ウィスター系雄性ラットを出血致死させた後、phis
iologicalsalt solution (N
aCl 154mM,KCl 2.7mM CaCl2
0.9mM,HEPES 5mM pH7.4)10
mlを腹腔内に注入した。腹部を90秒間軽くマツサー
ジした後、開腹し、腹腔内細胞浮遊液を採取した。4
℃,5000rpmで5分間遠心分離して得た細胞のペ
レットに、上記整理食塩水にダルコースを1g/1リッ
トル当り添加した液に再浮遊させた。The results of examining the antiallergic action of the product of the present invention are described below. (1) Histamine release-inhibiting effect After bleeding and death of male Wistar rats,
iologicalsalt solution (N
aCl 154 mM, KCl 2.7 mM CaCl 2
0.9 mM, HEPES 5 mM pH 7.4) 10
ml was injected intraperitoneally. After lightly pine surgering the abdomen for 90 seconds, the abdomen was opened and an abdominal cell suspension was collected. Four
The pellet of cells obtained by centrifugation at 5000 rpm for 5 minutes at 5,000 ° C was resuspended in a solution prepared by adding 1 g / 1 liter of Dulcose to the above-mentioned saline solution.
【0018】単離肥満細胞浮遊液50μlに本発明1.
75mlを加え、37℃,15分間のインキュベートし
た後、48/80溶液(最約濃度10-7g/ml)20
0μlを添加し、さらに10分間培養した。氷冷により
反応を停止させ、遠心分離した上清および細胞に残存し
たヒスタミン含量を蛍光定量し、ヒスタミン遊離率を算
出した。本発明品を添加しないで同様に測定した場合の
値をコントロールとした。結果を表1に示す。The present invention was added to 50 μl of the isolated mast cell suspension.
After adding 75 ml and incubating at 37 ° C. for 15 minutes, 48/80 solution (maximum concentration 10 −7 g / ml) 20
0 μl was added, and the cells were further incubated for 10 minutes. The reaction was stopped by cooling with ice, and the histamine content remaining in the centrifuged supernatant and cells was fluorimetrically determined to calculate the histamine release rate. The value measured in the same manner without adding the product of the present invention was used as a control. The results are shown in Table 1.
【0019】[0019]
【表1】 [Table 1]
【0020】表1に示すように、本発明品は、アレルギ
ー反応の原因の一つであるヒスタミンの遊離を抑制して
いると言える。 (2)PCA反応 体重約150gの雄性ラットの背部体毛を除毛し、両側
背部の皮膚に等間隔に4個(合計8個)の目印をマジッ
クでつけ、この点にマウス抗卵白アルブミン抗体を正確
に皮内注射し、受動感作した。約3.5時間後、両側背
部の対称となる2点に、本発明品を皮内注射し、その3
0分後に、卵白アルブミン−エバンスブルー溶液を尾静
脈内注射した。30分後に動物を断頭致死させ、首の方
から皮膚を剥いで、皮膚内面より生じた円形あるいは楕
円形の青色斑の面積(単位mm2)を求めた。なお、比
較対照として生理食塩水を皮内注射したものを用いた。
表2に結果を示した。As shown in Table 1, it can be said that the product of the present invention suppresses the release of histamine, which is one of the causes of allergic reaction. (2) PCA reaction The back hair of a male rat weighing about 150 g was shaved, and four (8 in total) marks were placed on the skin on both sides of the back at equal intervals with a mouse anti-ovalbumin antibody. Precise intradermal injection and passive sensitization. Approximately 3.5 hours later, the product of the present invention was intradermally injected into two symmetrical points on both sides of the back.
After 0 minutes, ovalbumin-Evans blue solution was injected into the tail vein. After 30 minutes, the animals were killed by decapitation, the skin was peeled from the neck, and the area (unit: mm 2 ) of circular or elliptical blue spots formed on the inner surface of the skin was determined. As a comparative control, an intradermal injection of physiological saline was used.
The results are shown in Table 2.
【0021】[0021]
【表2】 [Table 2]
【0022】表2にから分かるように、本発明品は、P
CA反応を抑制していると言える。このことから、肥満
細胞上での抗原抗体反応それによる種々のケミカルメデ
ィエーターの遊離、さらに、遊離したケミカルメディエ
ーターによる血管透過性亢進などの一連の反応を抑制し
ていることが示唆される。 (3) ヒトでの臨床試験 まず、各種疾患のパネラーに本発明品を毎日朝晩2回、
アレルギー性胃炎なら飲用、アレルギー性結膜炎なら点
眼、アレルギー性鼻炎なら噴霧と、それぞれの疾患にあ
うような投与の仕方をし、1ケ月間継続使用させ、その
経過を診断し、本発明品の有効性を判断した。その結果
を表3に示した。なお、パネラーは、各本発明品、各疾
患に対して10名以上で行った。判定は、著明改善、改
善、やや改善、変化なし、中止で別け、有用率(著明改
善+改善+やや改善の全体の割合)で出した。また、判
定は専門の医師により行なった。As can be seen from Table 2, the product of the present invention has P
It can be said that the CA reaction is suppressed. This suggests that the antigen-antibody reaction on mast cells suppresses the release of various chemical mediators, and further the series of reactions such as vascular permeability enhancement by the released chemical mediators. (3) Clinical test in humans First, the product of the present invention is applied to panelists of various diseases twice daily in the morning and evening.
If allergic gastritis is taken for drinking, if allergic conjunctivitis is instilled, if allergic rhinitis is sprayed, administration is performed according to each disease, and the administration is continued for 1 month, the progress is diagnosed, and the effect of the present invention is effective. Judged the sex. The results are shown in Table 3. It should be noted that the panelists were conducted by 10 or more persons for each of the present invention products and each disease. Judgment was made according to significant improvement, improvement, slight improvement, no change, discontinuation, and the usefulness rate (significant improvement + improvement + overall improvement rate). The judgment was performed by a specialist doctor.
【0023】[0023]
【表3】 [Table 3]
【0024】表3から分かるように、本発明品全てにお
いて、各種アレルギーに対する抗アレルギー性があるこ
とが判明した。さらに、わずかな疾患ではあったが、ア
レルギー性血管炎、アレルギー性下痢、アレルギー性神
経炎の他、アレルギー性関節炎、アレルギー性喉頭炎な
ど、抗ヒスタミン剤とかステロイド剤などが使用される
パネラーにおいても有効であった。以上のように、本発
明は、様々なアレルギーに対して、米という安全なもの
から非常に優れた効果を有する抗アレルギー剤を得たの
である。なお、実施例およびそれに伴うデータは、玄米
の場合について記載したが、白米および92%以下の白
糠の場合についても同様の効果が認められた。As can be seen from Table 3, all the products of the present invention were found to have antiallergic properties against various allergies. Furthermore, although it is a slight disease, it is also effective for panelists who use antihistamines or steroids such as allergic vasculitis, allergic diarrhea, allergic neuritis, allergic arthritis, allergic laryngitis, etc. there were. As described above, the present invention has obtained an antiallergic agent having a very excellent effect from a safe rice as a variety of allergies. In addition, although the example and the data accompanying it are described for the case of brown rice, the same effect was observed for the case of white rice and white rice bran of 92% or less.
【0025】[0025]
(実施例1)胚芽のついたままの米1kgを25℃の水
につけ、3日間浸漬させ、米を発芽させた。この発芽米
をよく洗浄した後、50℃で24時間乾燥し、その後、
細かく微粉砕し、本発明品990gを得た。 (実施例2)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に水1500mlを添加、塩酸で
pHを落とし10日間放置した。その後、絞り機で絞
り、得た清澄液を中和して、本発明品1200mlと残
渣760gを得た。(Example 1) 1 kg of rice without germ was soaked in water at 25 ° C for 3 days to germinate rice. After thoroughly washing the germinated rice, it is dried at 50 ° C. for 24 hours, and then,
The product was finely pulverized to obtain 990 g of the product of the present invention. (Example 2) Brown rice was crushed to obtain a crushed brown rice product 500
g was obtained. 1500 ml of water was added to this pulverized product, the pH was lowered with hydrochloric acid, and the mixture was left for 10 days. Then, it was squeezed with a squeezing machine to neutralize the resulting clear liquid to obtain 1200 ml of the product of the present invention and 760 g of a residue.
【0026】(実施例3)実施例1で得られた本発明品
500gを用いて、実施例3と同様の操作を行い、別の
本発明品1190mlを得た。 (実施例4)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に液化酵素10gと水1500m
lを添加した。その後、徐々に温度を上げていき、5分
間煮沸抽出した後、冷却した。その後、絞り機で絞り、
本発明品1420mlと残渣560gを得た。Example 3 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 3 was carried out to obtain another 1190 ml of the product of the present invention. (Example 4) Brown rice is crushed to obtain 500 crushed brown rice.
g was obtained. Liquefaction enzyme 10g and water 1500m to this crushed material
1 was added. Then, the temperature was gradually raised, and the mixture was boiled and extracted for 5 minutes and then cooled. After that, squeeze with a wringer,
1420 ml of the product of the present invention and 560 g of a residue were obtained.
【0027】(実施例5)実施例1で得られた本発明品
500gを用いて、実施例4と同様の操作を行い、別の
本発明品1400mlを得た。 (実施例6)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に2N−NaOH1500mlを
添加して5日間放置した。その後、絞り機で絞り、清澄
液1350mlと残渣650gを得た。この清澄液を1
0N−HCLで中和して、本発明品1480mlを得
た。Example 5 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 4 was carried out to obtain 1400 ml of another product of the present invention. (Example 6) Brown rice is crushed by a crusher to obtain crushed brown rice 500
g was obtained. 1500 ml of 2N-NaOH was added to this pulverized product and the mixture was left for 5 days. Then, it was squeezed with a squeezing machine to obtain 1350 ml of the clear liquid and 650 g of the residue. 1 of this clarified liquid
It was neutralized with 0N-HCL to obtain 1480 ml of the product of the present invention.
【0028】(実施例7)実施例1で得られた本発明品
500gを用いて、実施例6と同様の操作を行い、別の
本発明品1490mlを得た。 (実施例8)玄米を粉砕機にかけ、玄米の粉砕物500
gを得た。この粉砕物に95%エタノール1500ml
を添加して、5日間放置した。その後、絞り機で絞り、
清澄液1300mlと残渣650gを得た。この清澄液
に水2000mlを添加し、ロータリーエバプレーター
で濃縮し、本発明品1500mlを得た。Example 7 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 6 was carried out to obtain another 1490 ml of the product of the present invention. (Embodiment 8) Brown rice is crushed to obtain a crushed brown rice product 500
g was obtained. 1500 ml of 95% ethanol is added to this pulverized product.
Was added and left for 5 days. After that, squeeze with a wringer,
1300 ml of clear liquid and 650 g of residue were obtained. 2000 ml of water was added to this clarified liquid and concentrated by a rotary evaporator to obtain 1500 ml of the product of the present invention.
【0029】(実施例9)実施例1で得られた本発明品
500gを用いて、実施例8と同様の操作を行い、別の
本発明品1500mlを得た。 (実施例10)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た、この粉砕物に麹300g,水1500ml
を加え、55℃で20時間放置した。その後、絞り機で
絞り、本発明品1230mlと残渣1000gを得た。Example 9 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 8 was carried out to obtain another 1500 ml of the product of the present invention. (Example 10) Brown rice was crushed to obtain a crushed brown rice product 50
0 g was obtained, and 300 g of koji and 1500 ml of water were added to this ground product.
Was added and the mixture was allowed to stand at 55 ° C. for 20 hours. Then, it was squeezed with a squeezing machine to obtain 1230 ml of the product of the present invention and 1000 g of a residue.
【0030】(実施例11)実施例1で得られた本発明
品500gを用いて、実施例10と同様の操作を行い、
別の本発明品1210mlを得た。 (実施例12)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に蛋白分解酵素2gと水150
0mlを加え、50℃で20時間放置した。その後、絞
り機で絞り、本発明品1310mlと残渣670gを得
た。(Example 11) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 10 was carried out,
1210 ml of another product of the present invention was obtained. (Example 12) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. 2 g of protease and 150 water
0 ml was added and the mixture was left at 50 ° C. for 20 hours. Then, the product was squeezed with a squeezing machine to obtain 1310 ml of the product of the present invention and 670 g of a residue.
【0031】(実施例13)実施例1で得られた本発明
品500gを用いて、実施例12と同様の操作を行い、
別の本発明品1380mlを得た。 (実施例14)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に脂肪分解酵素2gと水150
0mlを加え、50℃で20時間放置した。その後、絞
り機で絞り、本発明品1290mlと残渣680gを得
た。(Example 13) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 12 was carried out,
Another 1380 ml of the product of the present invention was obtained. (Example 14) Brown rice is crushed to obtain 50 crushed brown rice.
0 g was obtained. 2 g of lipolytic enzyme and 150 water
0 ml was added and the mixture was left at 50 ° C. for 20 hours. Then, it was squeezed with a squeezing machine to obtain 1290 ml of the product of the present invention and 680 g of a residue.
【0032】(実施例15)実施例1で得られた本発明
品500gを用いて、実施例14と同様の操作を行い、
別の本発明品1360mlを得た。 (実施例16)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に繊維分解酵素2gと水150
0mlを加え、50℃で20時間放置した。その後、絞
り機で絞り、本発明品1330mlと残渣650gを得
た。Example 15 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 14 was carried out,
Another 1360 ml of the product of the present invention was obtained. (Example 16) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. 2 g of fiber-degrading enzyme and 150 water
0 ml was added and the mixture was left at 50 ° C. for 20 hours. Then, the product was squeezed with a squeezing machine to obtain 1330 ml of the product of the present invention and 650 g of a residue.
【0033】(実施例17)実施例1で得られた本発明
品500gを用いて、実施例16と同様の操作を行い、
別の本発明品1370mlを得た。 (実施例18)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に澱粉分解酵素2gと水150
0mlを加え、55℃で20時間放置した。その後、絞
り機で絞り、本発明品1380mlと残渣600gを得
た。Example 17 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 16 was carried out,
Another 1370 ml of the product of the present invention was obtained. (Example 18) Brown rice was crushed to obtain a crushed brown rice product 50
0 g was obtained. 2g starch degrading enzyme and 150g water
0 ml was added and the mixture was left at 55 ° C. for 20 hours. Then, it was squeezed with a squeezing machine to obtain 1380 ml of the product of the present invention and 600 g of a residue.
【0034】(実施例19)実施例1で得られた本発明
品500gを用いて、実施例18と同様の操作を行い、
別の本発明品1400mlを得た。 (実施例20)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物にペクチン分解酵素2gと水1
500mlを加え、50℃で20時間放置した。その
後、絞り機で絞り、本発明品1320mlと残渣660
gを得た。Example 19 The same operation as in Example 18 was carried out using 500 g of the product of the present invention obtained in Example 1,
Another 1400 ml of the product of the present invention was obtained. (Example 20) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. Add 2 g of pectin-degrading enzyme and 1 part of water to this ground product.
500 ml was added and left at 50 ° C. for 20 hours. After that, squeezing with a squeezing machine, 1320 ml of the present invention product and residue 660
g was obtained.
【0035】(実施例21)実施例1で得られた本発明
品500gを用いて、実施例20と同様の操作を行い、
別の本発明品1300mlを得た。 (実施例22)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に蛋白分解酵素2g,脂肪分解
酵素2g,繊維分解酵素2g,澱粉分解酵素2g,ペク
チン分解酵素2gと水1500mlを加え、50℃で2
0時間放置した。その後、絞り機で絞り、本発明品14
20mlと残渣560gを得た。Example 21 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 20 was carried out,
Another 1300 ml of the product of the present invention was obtained. (Example 22) Brown rice is crushed to obtain a crushed brown rice product 50
0 g was obtained. To this ground product, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1500 ml of water were added, and the mixture was heated at 50 ° C. for 2 hours.
It was left for 0 hours. After that, the product of the present invention 14
20 ml and 560 g of residue were obtained.
【0036】(実施例23)実施例1で得られた本発明
品500gを用いて、実施例22と同様の操作を行い、
別の本発明品1440mlを得た。 (実施例24)実施例22と同様の操作をして、米の酵
素分解物2000gを得た。その後、徐々に温度を上げ
ていき、5分間煮沸抽出した後、冷却した。その後、絞
り機で絞り、本発明品1400mlと残渣550gを得
た。(Example 23) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 22 was carried out,
Another 1440 ml of the product of the present invention was obtained. (Example 24) The same operation as in Example 22 was carried out to obtain 2000 g of an enzymatic decomposition product of rice. Then, the temperature was gradually raised, and the mixture was boiled and extracted for 5 minutes and then cooled. Then, it was squeezed with a squeezing machine to obtain 1400 ml of the product of the present invention and 550 g of a residue.
【0037】(実施例25)実施例1で得られた本発明
品500gを用いて、実施例24と同様の操作を行い、
別の本発明品1420mlを得た。 (実施例26)玄米を粉砕機にかけ、玄米の粉砕物50
0gを得た。この粉砕物に麹300gと40%エタノー
ル1500mlを加え、55℃で48時間放置した。そ
の後、絞り機で絞り、清澄液1300mlと残渣850
gを得た。その後、清澄液に1000mlの水を加水
し、ロータリーエバプレーターで濃縮し、本発明品13
00mlを得た。Example 25 Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 24 was carried out,
1420 ml of another product of the present invention was obtained. (Example 26) Brown rice was crushed to obtain a crushed brown rice product 50
0 g was obtained. To this crushed product, 300 g of koji and 1500 ml of 40% ethanol were added, and the mixture was left at 55 ° C. for 48 hours. After that, squeeze with a squeezing machine and clarified liquid 1300 ml and residue 850
g was obtained. Then, 1000 ml of water was added to the clarified solution and concentrated with a rotary evaporator to obtain the product of the present invention 13
00 ml was obtained.
【0038】(実施例27)実施例1で得られた本発明
品500gを用いて、実施例26と同様の操作を行い、
別の本発明品1300mlを得た。 (実施例28)実施例4と同様にして、米の抽出物20
00gを得た。この抽出物に蛋白分解酵素2g,脂肪分
解酵素2g,繊維分解酵素2g,澱粉分解酵素2g,ペ
クチン分解酵素2gを添加し、50℃で24時間放置し
た。その後、絞り機で絞り、本発明品1400mlと残
渣580gを得た。(Example 27) The same operation as in Example 26 was carried out using 500 g of the product of the present invention obtained in Example 1,
Another 1300 ml of the product of the present invention was obtained. (Example 28) Rice extract 20 was prepared in the same manner as in Example 4.
00g was obtained. To this extract, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme were added, and the mixture was left at 50 ° C. for 24 hours. Then, it was squeezed with a squeezing machine to obtain 1400 ml of the product of the present invention and 580 g of a residue.
【0039】(実施例29)実施例1で得られた本発明
品500gを用いて、実施例28と同様の操作を行い、
別の本発明品1390mlを得た。 (実施例30)実施例24と同様にして、米の酵素分解
抽出物2000gを得た。この酵素分解抽出物に酵母を
添加し、16日間アルコール発酵した。その後、絞り機
で絞り、本発明品1880mlと残渣80gを得た。(Example 29) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 28 was carried out,
Another 1390 ml of the product of the present invention was obtained. (Example 30) In the same manner as in Example 24, 2000 g of an enzyme-decomposed extract of rice was obtained. Yeast was added to this enzyme-decomposed extract, and alcoholic fermentation was carried out for 16 days. Then, it was squeezed with a squeezing machine to obtain 1880 ml of the product of the present invention and 80 g of a residue.
【0040】(実施例31)実施例1で得られた本発明
品500gを用いて、実施例30と同様の操作を行い、
別の本発明品1800mlを得た。 (実施例32)実施例24と同様にして、米の酵素分解
抽出物2000gを得た。この酵素分解抽出物を煮沸殺
菌した後、37℃まで冷却し、前もって乳酸菌を培養し
たスターター200mlを添加後、よく攪拌密封し、3
7℃で2日間乳酸発酵を行った。その後、絞り機で絞
り、本発明品1380mlと残渣590gを得た。(Example 31) The same operation as in Example 30 was carried out using 500 g of the product of the present invention obtained in Example 1,
Another 1800 ml of the product of the present invention was obtained. (Example 32) In the same manner as in Example 24, 2000 g of an enzyme-decomposed extract of rice was obtained. The enzyme-decomposed extract was sterilized by boiling, cooled to 37 ° C., 200 ml of a starter in which lactic acid bacteria had been cultured in advance was added, and the mixture was well stirred and sealed, and
Lactic acid fermentation was performed at 7 ° C for 2 days. Then, it was squeezed with a squeezing machine to obtain 1380 ml of the product of the present invention and 590 g of a residue.
【0041】(実施例33)実施例1で得られた本発明
品500gを用いて、実施例32と同様の操作を行い、
別の本発明品1400mlを得た。 (実施例34)実施例24で得られた本発明品1000
mlに95%エタノール80mlを添加し、29日間酢
酸発酵を行った。その後、濾過をし、本発明品990m
lを得た。(Example 33) Using 500 g of the product of the present invention obtained in Example 1, the same operation as in Example 32 was carried out,
Another 1400 ml of the product of the present invention was obtained. (Example 34) The product 1000 of the present invention obtained in Example 24.
80 ml of 95% ethanol was added to ml and the acetic acid fermentation was performed for 29 days. Then, it is filtered and the product of the present invention 990 m
1 was obtained.
【0042】(実施例35)実施例1で得られた本発明
品500gを用いて、実施例34と同様の操作を行い、
別の本発明品1000mlを得た。 以上の実施例で得た本発明品は、用途に応じて適宜に使
用されるが、本発明品を配合して化粧水および乳液とす
る場合の実施例について、次に記載する。なお、配合例
は以下の実施例に限定されるものではない。(Example 35) The same operation as in Example 34 was carried out using 500 g of the product of the present invention obtained in Example 1,
Another 1000 ml of the product of the present invention was obtained. The products of the present invention obtained in the above examples are appropriately used depending on the intended use. Examples of the case where the products of the present invention are blended to make a lotion and a milky lotion will be described below. The formulation examples are not limited to the examples below.
【0043】(実施例36) 化粧水 実施例22で得られた本発明品 10.0重量% ソルビトール 3.0重量% グリセリン 5.0重量% 精製水 76.4重量% アラントイン 0.1重量% ポリオキシエチレンヒマシ油誘導体 0.5重量% エタノール 5 重量% 以上の配合材料を常法により混合溶解し、化粧水を得
た。Example 36 Lotion Water of the present invention obtained in Example 22 10.0% by weight Sorbitol 3.0% by weight Glycerin 5.0% by weight Purified water 76.4% by weight Allantoin 0.1% by weight Polyoxyethylene castor oil derivative 0.5% by weight Ethanol 5% by weight The above ingredients were mixed and dissolved by a conventional method to obtain a lotion.
【0044】(実施例37) 乳液 実施例30で得られた本発明品 20.0重量% ステアリン酸 1.3重量% セタノール 0.7重量% ミツロウ 2.0重量% ポリオキシエチレン(11) モノオレイン酸エステル 1.2重量% グリセリンモノステアリン酸エステル 0.8重量% クインスシード抽出液(5%水溶液) 15.0重量% ジプロピレングリコール 5.0重量% エタノール 3.0重量% メチルパラベン 0.3重量% 香料 0.3重量% 精製水 50.4重量%(Example 37) Emulsion The product of the present invention obtained in Example 2 20.0% by weight Stearic acid 1.3% by weight Cetanol 0.7% by weight Beeswax 2.0% by weight Polyoxyethylene (11) Mono Oleic acid ester 1.2% by weight Glycerine monostearate 0.8% by weight Quinceseed extract (5% aqueous solution) 15.0% by weight Dipropylene glycol 5.0% by weight Ethanol 3.0% by weight Methylparaben 0.3 % By weight Fragrance 0.3% by weight Purified water 50.4% by weight
【0045】精製水にジプロピレングリコールを加え、
加熱攪拌し、温度を70℃に保持し、これに本発明品、
クインスシード抽出液、香料、エタノール以外の原料を
加えて攪拌し、次に、ホモジナイザーで均一に乳化させ
る。得られた乳化液を冷却しながら攪拌下に、残りのも
のを徐々に加え、室温に冷却して乳液を得た。Dipropylene glycol was added to purified water,
The mixture is heated and stirred, and the temperature is maintained at 70 ° C.
A quince seed extract, a fragrance, and ingredients other than ethanol are added and stirred, and then uniformly emulsified with a homogenizer. While cooling the obtained emulsion, the rest of the emulsion was gradually added to the emulsion and cooled to room temperature to obtain an emulsion.
【0046】[0046]
【発明の効果】本発明によれば、継続的に内服あるいは
外用することにより、簡単に、全く安全で、しかも、抗
アレルギー効果を持つ優れた抗アレルギー剤が得られ
る。米は今まで主食であったため、食以外の新規な分野
での製法、利用用途はほとんど開発されていなかった。
さらに、米は今まで主食とされてきたものであり、安全
性も十分に実証されているものである。すなわち、本発
明は、非常に優れた抗アレルギー剤を見出したばかりで
なく、米の過剰生産といわれる現在、新たな利用用途を
見出したこと、および米のイメージアップによる消費拡
大を図り得ることは、極めて有意義なことである。INDUSTRIAL APPLICABILITY According to the present invention, an excellent antiallergic agent which is simple, completely safe, and has an antiallergic effect can be obtained by continuous oral administration or external use. Since rice has been the staple food until now, little has been developed about its manufacturing method and use in new fields other than food.
Furthermore, rice has been the staple food until now, and its safety has been well demonstrated. That is, the present invention not only finds a very excellent anti-allergic agent, but is now said to be overproduction of rice, has found a new use application, and that it is possible to increase consumption by improving the image of rice, It is extremely meaningful.
Claims (5)
いはこれを含有してなる抗アレルギー剤。1. An anti-allergic agent comprising a crushed product of germinated rice as it is or containing it.
まま、あるいはこれを含有してなる抗アレルギー剤。2. An anti-allergic agent comprising rice or a germinated rice extract as it is or containing the same.
解または麹を作用させたものをそのまま、あるいはこれ
を含有してなる抗アレルギー剤。3. An anti-allergic agent, which is obtained by enzymatically decomposing or hydrolyzing rice hydrolyzed with hydrolyzed rice, or containing it.
り、その抽出前、抽出と同時または抽出後に酵素分解ま
たは麹を作用させたものをそのまま、あるいはこれを含
有してなる抗アレルギー剤。4. An anti-allergic agent which is obtained by extracting rice or sprouted rice with enzymatic decomposition or koji before or after extraction, simultaneously with or after extraction, or containing the same.
酵素分解または麹を作用させたものに、アルコール発
酵、あるいは有機酸発酵を行なったものをそのまま、あ
るいはこれを含有してなる抗アレルギー剤。5. An anti-allergic agent comprising rice or germinated rice extract or enzyme-decomposed or koji-acted, alcohol-fermented or organic acid-fermented as it is or containing it. .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30263694A JP3811198B2 (en) | 1993-11-17 | 1994-11-14 | Antiallergic agent from rice |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30967393 | 1993-11-17 | ||
JP5-309673 | 1993-11-17 | ||
JP30263694A JP3811198B2 (en) | 1993-11-17 | 1994-11-14 | Antiallergic agent from rice |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07252158A true JPH07252158A (en) | 1995-10-03 |
JP3811198B2 JP3811198B2 (en) | 2006-08-16 |
Family
ID=26563210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30263694A Expired - Lifetime JP3811198B2 (en) | 1993-11-17 | 1994-11-14 | Antiallergic agent from rice |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3811198B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001095922A1 (en) * | 2000-06-14 | 2001-12-20 | Fukuda, Koji | Remedies for allergic diseases and process for producing the same |
JP2005263722A (en) * | 2004-03-19 | 2005-09-29 | Ozeki Corp | Method for producing functional raw material from brewing by-product, and functional raw material yielded thereby |
WO2006098603A3 (en) * | 2005-03-18 | 2006-11-30 | Unigen Inc | Composition comprising isoorientin for suppressing histamine |
JP2009292785A (en) * | 2008-06-06 | 2009-12-17 | Gekkeikan Sake Co Ltd | Immunomodulator and antiallergic agent containing the same |
JP2010051311A (en) * | 2008-07-31 | 2010-03-11 | Niigata Prefecture | Food and drink having antiallergic function and method for producing the same |
US8771761B2 (en) | 2006-10-12 | 2014-07-08 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
WO2023051029A1 (en) * | 2021-09-30 | 2023-04-06 | 上海家化联合股份有限公司 | Glutinous rice fermentation extract and anti-eczema application thereof |
-
1994
- 1994-11-14 JP JP30263694A patent/JP3811198B2/en not_active Expired - Lifetime
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001095922A1 (en) * | 2000-06-14 | 2001-12-20 | Fukuda, Koji | Remedies for allergic diseases and process for producing the same |
US9061039B2 (en) | 2002-03-01 | 2015-06-23 | Unigen, Inc. | Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors |
US9849152B2 (en) | 2002-04-30 | 2017-12-26 | Unigen, Inc. | Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent |
US9655940B2 (en) | 2002-04-30 | 2017-05-23 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US9370544B2 (en) | 2002-04-30 | 2016-06-21 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
US9622964B2 (en) | 2003-04-04 | 2017-04-18 | Unigen, Inc. | Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
JP2005263722A (en) * | 2004-03-19 | 2005-09-29 | Ozeki Corp | Method for producing functional raw material from brewing by-product, and functional raw material yielded thereby |
JP2008533131A (en) * | 2005-03-18 | 2008-08-21 | ユニジェン インク. | Histamine-suppressing composition containing isoorientin |
WO2006098603A3 (en) * | 2005-03-18 | 2006-11-30 | Unigen Inc | Composition comprising isoorientin for suppressing histamine |
US8771761B2 (en) | 2006-10-12 | 2014-07-08 | Unigen, Inc. | Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
JP2009292785A (en) * | 2008-06-06 | 2009-12-17 | Gekkeikan Sake Co Ltd | Immunomodulator and antiallergic agent containing the same |
JP2010051311A (en) * | 2008-07-31 | 2010-03-11 | Niigata Prefecture | Food and drink having antiallergic function and method for producing the same |
WO2023051029A1 (en) * | 2021-09-30 | 2023-04-06 | 上海家化联合股份有限公司 | Glutinous rice fermentation extract and anti-eczema application thereof |
Also Published As
Publication number | Publication date |
---|---|
JP3811198B2 (en) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4795841B2 (en) | Germinated barley fermented product | |
JPH07252129A (en) | Epidermal stratum corneum health enhancer from rice | |
JPH07252158A (en) | Antiallergic agent from rice | |
JP2000143524A (en) | Antiinflammatory agent containing extract of amaranthus | |
JPH08119870A (en) | Turnover normalizer from rice | |
CN107303255B (en) | Sorghum fermentation product having anti-inflammatory, anti-allergic and atopic skin improving effects, its preparation method and cosmetic composition | |
JPH0892113A (en) | Anti-inflammatory drug from rice | |
KR100534074B1 (en) | Cosmetic composition containing grain extract and fermented grain phellinus linteus extract, and cosmetics containing the same | |
JP7170357B2 (en) | External agent for hair growth | |
JPH0873367A (en) | Atopic dermatitis preventive and therapeutic agent from rice | |
JPH0710767A (en) | Skin remedy from rice | |
JP3779735B2 (en) | Treatment for bed slippage from rice | |
JPH08119873A (en) | Helicobacter pylori disinfectant from rice | |
JP3795541B2 (en) | Lipid peroxide inhibitor from rice | |
JP3795542B2 (en) | Antihypertensive agent from rice | |
JP3779739B2 (en) | Salt damage inhibitor from rice | |
JP6158147B2 (en) | Whitening agent and internal or external composition containing the same | |
JP3678436B2 (en) | Antiulcer agent | |
JP3678435B2 (en) | Hot compress | |
JP3795543B2 (en) | 5α-reductase inhibitor | |
JPH07165595A (en) | Lipid metabolism improver from rice | |
JP3779737B2 (en) | Stress relieving agent from rice | |
JPH07165557A (en) | Acne prevention and treatment agent from rice | |
JPH07112937A (en) | Obesity preventive and therapeutic agent from rice | |
JP6533478B2 (en) | Whitening agent and internal or external composition containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051129 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060221 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060424 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060523 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060526 |
|
R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100602 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110602 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120602 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120602 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130602 Year of fee payment: 7 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |